ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Gastroenterology · Clin Gastroenterol Hepatol · 2026-08-03

AGA expert review (no systematic review or formal evidence grading) advises individualised, shared decisions on Barrett's oesophagus and colorectal surveillance or screening in adults over 75, weighing comorbidities, life expectancy, risks and patient preferences.

Guideline
Calderwood et al. AGA Clinical Practice Update on Surveillance of Metaplastic and Premalignant Conditions of the Esophagus and Colorectum in Older Adults: Expert Review
Gastroenterology · Aliment Pharmacol Ther · 2026-07-23

In 22 analysed adults with prior bile acid malabsorption, a 3-week 8-strain probiotic lowered faecal primary bile acids versus placebo (median change −5.7% vs +9.8%; p=0.012) and altered the microbiome, but symptoms, permeability and SCFA did not differ.

RCTn = 24
Damianos et al. Clinical Trial: Multi-Strain Probiotic Improves Bile Acid Profile, Microbiome, and Metabolomic Parameters in Patients With History of Bile Acid Malabsorption-A Randomized, Controlled Trial
Gastroenterology · Lancet Gastroenterol Hepatol · 2026-06-24

In 41 adults and adolescents with eosinophilic gastritis (40 analysed), 12 weeks of dupilumab reduced gastric eosinophil counts more than placebo (mean relative change −50% vs −4%; difference −47 points, p<0·0001). Adverse events were similar (81% vs 85%).

RCTn = 41
Gonsalves et al. Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
Gastroenterology · Gastroenterology · 2026-05-19

Meta-analysis of 13 RCTs (693 patients) with IBS: faecal microbiota transplantation versus placebo did not significantly reduce non-improvement of symptoms at 12 weeks by intention to treat (RR 0.72, 95% CI 0.50–1.03; very low certainty). Adverse events were similar.

Meta-analysisn = 693
Aumpan et al. Fecal Microbiota Transplantation for Symptom Improvement in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.